1. Home
  2. ANNX vs SHYF Comparison

ANNX vs SHYF Comparison

Compare ANNX & SHYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANNX
  • SHYF
  • Stock Information
  • Founded
  • ANNX 2011
  • SHYF 1975
  • Country
  • ANNX United States
  • SHYF United States
  • Employees
  • ANNX N/A
  • SHYF N/A
  • Industry
  • ANNX Biotechnology: Pharmaceutical Preparations
  • SHYF Auto Manufacturing
  • Sector
  • ANNX Health Care
  • SHYF Consumer Discretionary
  • Exchange
  • ANNX Nasdaq
  • SHYF Nasdaq
  • Market Cap
  • ANNX 362.4M
  • SHYF 428.3M
  • IPO Year
  • ANNX 2020
  • SHYF N/A
  • Fundamental
  • Price
  • ANNX $2.81
  • SHYF $11.17
  • Analyst Decision
  • ANNX Strong Buy
  • SHYF Strong Buy
  • Analyst Count
  • ANNX 7
  • SHYF 2
  • Target Price
  • ANNX $15.80
  • SHYF $15.50
  • AVG Volume (30 Days)
  • ANNX 1.3M
  • SHYF 174.5K
  • Earning Date
  • ANNX 03-25-2025
  • SHYF 02-20-2025
  • Dividend Yield
  • ANNX N/A
  • SHYF 1.79%
  • EPS Growth
  • ANNX N/A
  • SHYF N/A
  • EPS
  • ANNX N/A
  • SHYF N/A
  • Revenue
  • ANNX N/A
  • SHYF $786,176,000.00
  • Revenue This Year
  • ANNX N/A
  • SHYF N/A
  • Revenue Next Year
  • ANNX N/A
  • SHYF $9.38
  • P/E Ratio
  • ANNX N/A
  • SHYF N/A
  • Revenue Growth
  • ANNX N/A
  • SHYF N/A
  • 52 Week Low
  • ANNX $2.64
  • SHYF $9.81
  • 52 Week High
  • ANNX $8.40
  • SHYF $17.56
  • Technical
  • Relative Strength Index (RSI)
  • ANNX 26.19
  • SHYF 38.73
  • Support Level
  • ANNX $2.64
  • SHYF $11.81
  • Resistance Level
  • ANNX $3.24
  • SHYF $13.75
  • Average True Range (ATR)
  • ANNX 0.23
  • SHYF 0.61
  • MACD
  • ANNX -0.02
  • SHYF -0.01
  • Stochastic Oscillator
  • ANNX 14.77
  • SHYF 0.39

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About SHYF The Shyft Group Inc.

The Shyft Group Inc is engaged in specialty vehicle manufacturing and assembly for commercial vehicles (including last-mile delivery, specialty service, and vocation-specific upfit segments) and recreational vehicle industries. Its products include walk-in vans, truck bodies, cargo vans, and pick-up truck upfits used in e-commerce/parcel delivery, upfit equipment used in the mobile retail and utility trades, as well as luxury Class A diesel motorhome custom chassis and contract manufacturing and assembly services. It also supplies replacement parts and offers repair, maintenance, field service, and refurbishment services for the vehicles that the company manufactures.

Share on Social Networks: